Browse Related Topics For:

Pharmaceutical Industry The United States Food and Drug Administration

427
Prescription Drugs
254
Biosimilars
208
Generic Drugs
208
Patents
201
Pharmaceutical Patents
193
Medical Devices
139
Patent Litigation
136
Patent Infringement
135
BPCIA
124
ANDA
114
Off-Label Promotion
111
Biologics
96
Hatch-Waxman
91
Healthcare
87
FDCA
80
Amgen
78
First Amendment
76
Sandoz
70
Manufacturers
66
Popular
61
Labeling
61
Sandoz v Amgen
60
Off-Label Use
58
FDA Approval
57
Draft Guidance
51
SCOTUS
50
Preemption
48
HHS
48
Life Sciences
47
Clinical Trials
46
Amarin
39
Free Speech
39
Medicare
38
Affordable Care Act
38
Health Care Providers
37
Patent-in-Suit
35
21st Century Cures Initiative
34
Medicaid
34
Misbranding
33
Intellectual Property Protection
33
Patent Dance
32
Advertising
32
Failure To Warn
32
False Claims Act (FCA)
32
FTC
32
Warning Labels
31
Marketing
31
Pharmacies
30
Commercial Marketing
29
Drug Compounding
29
Preliminary Injunctions
28
CMS
26
Appeals
26
Biotechnology
26
Commercial Speech
26
Trump Administration
24
Comment Period
24
DOJ
24
Enforcement Actions
23
Product Labels
22
Drug Pricing
21
Drug Safety
21
Medical Research
21
Mylan Pharmaceuticals
21
Physicians
21
Teva Pharmaceuticals
20
NIH
20
Orphan Drugs
20
Warning Letters
19
AbbVie
18
aBLA
18
Apotex
18
DSCSA
18
New Guidance
17
Biologics Price Competition and Innovation Act of 2009
17
Citizen Petitions
17
EU
17
Patent Applications
17
Safe Harbors
16
Caronia
16
FFDCA
16
Hospira
16
Notice Requirements
15
Class Action
15
Hospitals
15
Opioid
15
Regulatory Oversight
15
Supply Chain
14
Antitrust Litigation
14
Corporate Counsel
14
Final Guidance
14
Final Rules
14
Healthcare Reform
14
OIG
14
Pfizer
14
PHRMA
14
Regulatory Standards
14
Social Media
14
Summary Judgment
14
USPTO
13
Johnson & Johnson
13
Legislative Agendas
13
Product Exclusivity
13
Public Health Service Act
13
Reporting Requirements
13
Reverse Payment Settlement Agreements
13
Settlement
12
Bayer
12
Declaratory Judgments
12
DQSA
12
GlaxoSmithKline
12
Health Insurance
12
HIPAA
12
Innovation
12
Investigational New Drug Application (IND)
12
Multidistrict Litigation
12
Pending Legislation
12
Proposed Legislation
12
Proposed Regulation
12
Public Meetings
12
REMS
12
Research and Development
12
SEC
12
User Fees
11
Criminal Prosecution
11
Cybersecurity
11
Fraud
11
Obviousness
11
Product Defects
11
Whistleblowers
10
21st Century Cures Act
10
Anti-Kickback Statute
10
Design Defects
10
Discovery
10
Drug Approvals
10
Drug Distribution
10
European Medicines Agency (EMA)
10
FTC v Actavis
10
Interchangeability
10
PLIVA v Mensing
10
Professional Conferences
10
Public Comment
10
Public Health
10
Qui Tam
10
Section 340B
9
Actavis Inc.
9
Antitrust Violations
9
Birth Defects
9
Cancer
9
Civil Monetary Penalty
9
Enforcement
9
False Advertising
9
Medicare Part D
9
Negligence
9
Orange Book
9
Personal Jurisdiction
9
Prior Art
9
Social Networks
9
Trademarks
8
3D Printing
8
Competition
8
Disclosure Requirements
8
Inter Partes Review (IPR) Proceeding
8
Janssen Pharmaceuticals
8
Merck
8
Misleading Statements
8
Motion to Dismiss
8
Novartis
8
OPDP
8
Pay-For-Delay
8
Product Recalls
8
Regulatory Agenda
7
Administrative Procedure Act
7
Adverse Events
7
Allergan Inc
7
Black Box Warnings
7
CDC
7
Certiorari
7
CGMP
7
CHIP
7
Congressional Investigations & Hearings
7
Expert Testimony
7
Federal Rule 12(b)(6)
7
GAO
7
Health Information Technologies
7
HRSA
7
Informed Consent
7
Patent Invalidity
7
PHSA
7
Product Hopping
7
Public Hearing
7
Scientific Research
7
Sherman Act
7
Side Effects
7
Standing
7
Strict Liability
7
Watson Pharmaceuticals
6
Abbott Laboratories
6
America Invents Act
6
Barack Obama
6
Big Data
6
Canada
6
Compliance
6
FDARA
6
Federal Funding
6
Federal Rules of Civil Procedure
6
FOIA
6
Gilead Sciences
6
Healthcare Fraud
6
Inadequate Warning
6
Learned Intermediary
6
Misrepresentation
6
OMB
6
Otsuka Pharmaceutical
6
Patient Safety
6
PDUFA
6
Personalized Medicine
6
Pleading Standards
6
Securities Fraud
6
Unfair or Deceptive Trade Practices
6
Universal Health Services Inc v United States ex rel Escobar
6
Websites
6
World Health Organization
5
510(k) RTA
5
Amgen v Sandoz
5
Anti-Competitive
5
Antitrust Provisions
5
Boehringer
5
Brand
5
Causation
5
Celltrion
5
Coherus
5
DEA
5
Diagnostic Tests
5
Eli Lilly
5
Exclusivity
5
Fifth Amendment
5
Food and Drug Administration Amendments Act (FDAAA)
5
HCEI
5
Illegal Drugs
5
Infringement
5
Injunctive Relief
5
Insider Trading
5
Inspections
5
IRB
5
Jurisdiction
5
Medicare Part B
5
Medtronic
5
Mergers
5
Monopolization
5
New Legislation
5
On-Sale Bar
5
Outsourcing
5
Patent Term Extensions
5
Securities Litigation
5
Stem cells
5
Unfair Competition
5
USDA
5
Verification Requirements
5
Wholesale
4
Advisory Committee
4
Bristol-Myers Squibb
4
Celebrity Endorsements
4
Center for Drug Evaluation and Research (CDER)
4
Chevron Deference
4
Claim Construction
4
Class Certification
4
Classen Immunotherapies
4
Databases
4
Dietary Supplements
4
Direct to Consumer Sales
4
DNA
4
Durable Medical Equipment
4
Elan Pharmaceuticals
4
Endo Pharmaceuticals
4
EPA
4
Evidence
4
False Statements
4
FCPA
4
FD&C Act
4
FDA Warning Letters
4
FDASIA
4
Federal Budget
4
Federal Pilot Programs
4
Federal Register
4
GDUFA
4
Genentech
4
Genetic Testing
4
Home Health Care
4
IRS
4
Kickbacks
4
Laboratory Developed Tests
4
Lanham Act
4
Legislative Committees
4
Licenses
4
Long Term Care Facilities
4
Materiality
4
MedPAC
4
Mensing
4
Mental Health
4
Misleading Impressions
4
No-AG Agreement
4
OxyContin
4
Patent Trial and Appeal Board
4
Patients
4
Permanent Injunctions
4
Pregnancy
4
Reimbursements
4
Risk Assessment
4
Risk Management
4
Samsung
4
Secretary of HHS
4
Settlement Agreements
4
Shareholders
4
Substance Abuse
4
Takeda Pharmaceuticals
4
Technology
4
Trade Secrets
4
Transparency
4
UAW
3
Acquisitions
3
Allergan v Sandoz
3
Article III
3
Audits
3
Biogen Idec
3
Biopharmaceutical
3
Burden of Proof
3
CEOs
3
China
3
Clinical Laboratories
3
Confidential Information
3
Conflicts of Interest
3
Contraceptives
3
Controlled Substances Act
3
Cosmetics
3
Covered Entities
3
Data Breach
3
Data Protection
3
Daubert Standards
3
Declaratory Relief
3
Disgorgement
3
Dismissals
3
Due Process
3
EHR
3
Employee Benefits
3
Exclusive Dealing Agreements
3
Extrapolation
3
Financial Conduct Authority (FCA)
3
Financial Institutions
3
Financial Markets
3
First-to-File
3
Food Recalls
3
Foreign Manufacturers
3
FSMA
3
Generic
3
Genzyme
3
Google
3
Guidance Update
3
Hackers
3
Healthcare Facilities
3
Imports
3
Innovator Liability
3
Intellectual Property Litigation
3
Internet
3
Interstate Commerce
3
Inventors
3
Kim Kardashian
3
License Agreements
3
Medical Malpractice
3
Medicare Advantage
3
Method Claims
3
Mobile Apps
3
Mutual Pharmaceuticals v Bartlett
3
Notice Provisions
3
OCR
3
openFDA
3
Outsourcing Facilities
3
Pain Management
3
Par Pharmaceutical
3
Partnerships
3
Patent-Eligible Subject Matter
3
Patient Privacy Rights
3
Pediatrics
3
Petition for Writ of Certiorari
3
Premarket Approval Applications
3
Prescription Drug Coverage
3
Private Right of Action
3
PSLRA
3
Public Disclosure
3
Public Health Insurance Marketplace
3
Purple Book
3
Putative Class Actions
3
Quality Control Plan
3
Regulatory Reform
3
Relators
3
Repeal
3
Rule-of-Reason Analysis
3
Rulemaking Process
3
Safety Standards
3
Sanofi
3
Sealed Records
3
Securities
3
Securities Violations
3
SNDAs
3
Software
3
Stark Law
3
Strategic Enforcement Plan
3
Subject Matter Jurisdiction
3
Sunshine Act
3
Tax Credits
3
Telemedicine
3
The Common Rule
3
Twitter
3
Twombly/Iqbal Pleading Standard
3
Venture Capital
3
Veterinary Products
3
Wrongful Death
3
Wyeth
2
35 U.S.C. § 271(e)(1)
2
ACOs
2
All Writs Act
2
American Medical Association
2
Amgen v Apotex
2
Amicus Briefs
2
AMP v Myriad
2
Animal Drugs
2
Animal Testing
2
Anti-Steering Rules
2
Antibiotics
2
Antitrust Injuries
2
AstraZeneca
2
Attorney Generals
2
Attorney-Client Privilege
2
Aurobindo Pharmaceuticals
2
Bifurcation
2
Biometric Information
2
CAFC
2
Capital Raising
2
Cephalon
2
Chemicals
2
Clear and Convincing Evidence
2
Co-payments
2
Combination Products
2
Congressional Budget Office
2
Congressional Committees
2
Consent Decrees
2
Consumer Expectations Test
2
Consumer Fraud
2
Controlled Substances
2
Conversion
2
Corporate Integrity Agreement
2
Counterclaims
2
Counterfeit Drugs
2
Crowdfunding
2
Cyber Threats
2
Daiichi Sankyo
2
DaimlerChrysler v Bauman
2
De Novo Standard of Review
2
Delays
2
Department of Veterans Affairs
2
Digital Health
2
Disclaimers
2
Discussion Draft
2
Distributors
2
Diversity Jurisdiction
2
DMEPOS
2
Dodd-Frank
2
Drug & Alcohol Abuse
2
Duty to Deal
2
Duty to Warn
2
Ethics
2
Executive Orders
2
Exemptions
2
Failure To Disclose
2
Failure To State A Claim
2
False Implied Certification Theory
2
Fast Track Process
2
FDA Commissioner
2
Federal Health Care Programs (FHCP)
2
Federal Question Jurisdiction
2
Federal v State Law Application
2
First Impression
2
Fraudulent Joinder
2
Funding
2
General Jurisdiction
2
Genetic Materials
2
Government Investigations
2
GPOs
2
Health & Safety Standard
2
Health Insurance Exchanges
2
Health Safety
2
HITECH
2
HIV
2
Human Rights
2
Indictments
2
Induced Infringement
2
Infectious Diseases
2
Injunctions
2
Inpatient Prospective Payment System (IPPS)
2
Insurance Industry
2
Internal Controls
2
International Arbitration
2
Internet Marketing
2
Investigational Device Exemptions
2
Investment
2
Investors
2
IP License
2
License Applications
2
Licensing Rules
2
Manufacturing Defects
2
Marijuana
2
Marketing Authorization Application
2
Medicaid Expansion
2
Medical Reimbursement
2
Medicare Prescription Drug Improvement and Modernization Act (MMA)
2
Mental Health Parity Rule
2
Mobile Health Apps
2
Mootness
2
Motion To Stay
2
NAFTA
2
National Cancer Moonshot
2
Native American Issues
2
Negligent Misrepresentation
2
Nike
2
Non-Public Information
2
Obama Administration
2
Office of Regulatory Affairs (ORA)
2
Omissions
2
Omnibus Guidance
2
Omnicare
2
Omnicare v Laborers District Council
2
Online Advertisements
2
OTC
2
Over-the-Counter Sales
2
Patent Exhaustion
2
Patent Expiration
2
Pay-Per-Click
2
PCORI
2
Personally Identifiable Information
2
Pharmacist
2
POM Wonderful
2
Post-Grant Review
2
Presidential Elections
2
Price Gouging
2
Proposed Amendments
2
Public Safety
2
Publicly-Traded Companies
2
Qualified Small Employer Health Reimbursement Plan (QSEHRAs)
2
RanBaxy
2
Registration Requirement
2
Remand
2
Retaliation
2
Reversal
2
Reverse Payments
2
RICO
2
Right to Try
2
Ripeness
2
Risk Mitigation
2
Safety Precautions
2
Samsung Bioepis
2
Sanctions
2
Schering-Plough
2
Scientific Evidence
2
Search Engines
2
Section 503
2
Securities Exchange Act
2
Skilled Nursing Facility
2
Small Business
2
Solicitor General
2
Spectrum
2
St Jude Medical Center
2
Standard of Review
2
Startups
2
State Law Claims
2
Statute of Limitations
2
Stock Drop Litigation
2
Stocks
2
Subsidies
2
Tax Deductions
2
Telehealth
2
Television Commercials
2
Testimony
2
Transfer of Venue
2
TRO
2
Two-Midnight Rule
2
UK
2
User-Generated Content
2
Vaccinations
2
Waivers
2
Warner Chilcott
2
Warranties
2
Webinars
2
Wireless Technology
2
Written Descriptions
2
Yates Memorandum
2
Young Lawyers
1
23andMe
1
Acceleration
1
Accounting Controls
1
Actos
1
Actual Injuries
1
Addiction Equity Act
1
Additive Manufacturing
1
Administrative Appointments
1
Administrative Authority
1
Administrative Proceedings
1
Admissible Evidence
1
Advance Notice
1
Advisory Opinions
1
Aerospace
1
AHRQ
1
AIDS
1
AIG
1
ALJ
1
All Natural
1
Alternative Payment Models (APM)
1
Alzheimer's
1
Amazon
1
Ambulatory Surgery Centers
1
Amended Complaints
1
Amended Regulation
1
Amended Rules
1
American Health Care Act (AHCA)
1
Amgen Inc. v Connecticut Retirement Plans
1
Animal Food
1
Animal Health
1
Anti-Monopoly
1
Anti-Retaliation Provisions
1
Antimicrobials
1
Antitrust Conspiracies
1
Antitrust Division
1
App Developers
1
Applicable Manufacturers
1
Applications
1
Appointments Clause
1
Appropriate Equitable Relief
1
Arbitration
1
Article II
1
Artificial Intelligence
1
Asbestos
1
Asbestos Litigation
1
Asia
1
Asset Seizure
1
Assignments
1
Attestation Deadlines
1
Australia
1
Automatic Stay
1
Automobile Recall
1
Automotive Industry
1
Bank of New York (BNY) Mellon
1
Banking Sector
1
Barclays
1
Bayh-Dole Act
1
Benefit Plan Reimbursements
1
Best Buy
1
Best Management Practices
1
Best Practices
1
Billing
1
Bilski
1
Biocon
1
biologic
1
Bipolar Disorder
1
Birth Control Pill
1
Boston Scientific
1
BPCI
1
Brand Name Prescription Drugs
1
Breach of Duty
1
Breach of Implied Contract
1
Breach of Warranty
1
Breakthrough Therapy Designation
1
Budget Cuts
1
Build America Investment Initiative
1
Business Associates
1
Business Development
1
C&DIs
1
CA Supreme Court
1
Campaign Finance Reform
1
Canadian Intellectual Property Office
1
Cartwright Act
1
Carve Out Provisions
1
Caterpillar
1
CCIIO
1
CERCLA
1
Certification Requirements
1
CFPB
1
Chief Compliance Officers
1
Childrens' Motrin
1
Chilling Effect
1
Chip and PIN
1
Cipro
1
Citizen Suits
1
Claim Preclusion
1
Clean Air Act
1
Clean Water Act
1
clear
1
Clearance
1
CLIA
1
Climate Action Plan
1
Clinical Laboratory Testing
1
CLS Bank v Alice Corp
1
CMMI
1
COBRA
1
Coca Cola
1
Collateral Estoppel
1
Commerce Clause
1
Commitment Letter
1
Common Law Claims
1
Community Health Systems
1
Compensation & Benefits
1
Compensatory Awards
1
Compensatory Damages
1
Competitive Bidding
1
Complete Genomics
1
Comptroller of the Treasury v Wynne
1
Confidential Documents
1
Confidentiality Policies
1
Conflicting Proposals
1
Congressional Review Act
1
Conspiracies
1
Constitutional Challenges
1
Consumer Complaint Management
1
Consumer Product Safety Commission (CPSC)
1
Consumer Protection Act
1
Consumers Legal Remedies Act
1
Contamination
1
Contests & Promotions
1
Continuing Medical Education
1
Contraceptive Coverage Mandate
1
Contract Drafting
1
Contributory Infringement
1
Copyright
1
Corporate Misconduct
1
Corporate Officers
1
Corporate Restructuring
1
Corporate Taxes
1
Corrective Actions
1
Corruption
1
Cost-Sharing
1
Costco
1
Counterfeiting
1
Covenant Not to Sue
1
Covered Business Method Patents
1
Covered Recipients
1
CPUC
1
CREATE Act
1
Criminal Conspiracy
1
Criminal Convictions
1
Criminal Investigations
1
Criminal Penalties
1
Cross Motions
1
Cross-Border Transactions
1
Cruel & Unusual Punishment
1
Cuozzo Speed Technologies v Lee
1
Customs and Border Protection
1
CVM
1
Cyber Attacks
1
DaimlerAG
1
Damages
1
Data Breach Plans
1
Data Controller
1
Data Integrity
1
Data Mining
1
Data Security
1
Daubert Ruling
1
De Minimis Claims
1
Debit and Credit Card Transactions
1
Debt Ceiling
1
Deceptive Intent
1
Decision-Making Process
1
Defect
1
Defense Strategies
1
Deferred Prosecution Agreements
1
Delaware General Corporation Law
1
Department of Transportation (DOT)
1
Depositions
1
Deregulation
1
Derivation Proceeding
1
Device Classification
1
DHS
1
Diagnostic Imaging Services
1
Diagnostic Method
1
Direct Infringement
1
Direct Purchasers
1
Dirks v SEC
1
Disability Discrimination
1
Disclosure
1
Discounts
1
Disruptive Technology
1
Divided Infringement
1
Document Retention Policies
1
DOL
1
Domain Names
1
Double Jeopardy
1
Drug Testing
1
Drug Treatment
1
DSHEA
1
DSM
1
Due Diligence
1
E-Filing
1
EAR
1
Earn-Outs
1
EEOC
1
Eighth Amendment
1
Electronic Communications
1
Electronic Filing
1
Electronic Health Record Incentives
1
Electronic Medical Records
1
Electronic Records
1
Electronically Stored Information
1
Eleventh Amendment
1
Email
1
Embargo
1
Emerging Markets
1
Employer Group Health Plans
1
Employer Mandates
1
EMTs
1
En Banc Review
1
Environmental Policies
1
ERISA
1
Ernst & Young
1
EU-US Privacy Shield
1
European Food Safety Authority (EFSA)
1
Events
1
Evidence Suppression
1
Evidentiary Standards
1
Ex Post Facto Clause
1
Excessive Pricing
1
Excise Tax
1
Expanded Access Programs (EAPs)
1
Expedited Approval Process
1
Expedited FDA Approval
1
Expert Witness
1
Export Controls
1
Exports
1
Fair Notice
1
False Evidence
1
False Press Release
1
Falsified Documents
1
FBI
1
FCC
1
FDAMA
1
Federal Aviation Administration (FAA)
1
Federal Contractors
1
Federal Rule 12(b)(1)
1
FedEx
1
Fee-for-Service
1
Fee-Shifting
1
Fees
1
FERC
1
Fiduciary Duty
1
Fiduciary Rule
1
Financial CHOICE Act
1
Financial Statements
1
Flame Retardant
1
Flexible Spending Accounts
1
FMCSA
1
Food & Drug Regulations
1
Food Allergies
1
Food Labeling
1
Food Poisoning
1
Foreign Corporations
1
Foreign Earned Income
1
Foreign Investment
1
Foreign Tax
1
Foreseeability
1
Forest Laboratories
1
Form 10-K
1
Form 8-K
1
Forum Shopping
1
Fraud-on-the-Market
1
Fraudulent Inducement
1
FRCP 26
1
FRCP 9(b)
1
FSMB
1
FTC Act
1
General Electric
1
General Services Administration (GSA)
1
General Wellness Devices
1
Genetic Markers
1
Goldman Sachs
1
Good Cause
1
Good Clinical Practices
1
Goodyear
1
Government Studies
1
Grable Factors
1
Grocery Stores
1
gTLD
1
Guilty Pleas
1
Halliburton v Erica P. John Fund
1
Hazardous Substances
1
Hazardous Waste
1
HCPCS
1
Health Canada
1
Health Care Violations
1
Health IT
1
Health Savings Accounts
1
Healthcare Costs
1
Hedge Funds
1
HELP
1
Hewlett-Packard
1
Hip Replacement
1
HIPAA Audits
1
HIPAA Breach
1
Hoffman LaRoche
1
Home Depot
1
Honeybees
1
Hospice
1
Hospital Mergers
1
HRA
1
Human Genes
1
Human Genome Project
1
Hurricane Harvey
1
Hurricane Irma
1
ICD-10
1
Illegal Tipping
1
Implied Certification
1
Implied Preemption
1
Impression Products v Lexmark International
1
In-Person Exam
1
Incentives
1
Incident Response Plans
1
Income Taxes
1
Inconsistent Jury Verdicts
1
Indirect Infringement
1
Individual Mandate
1
Inducement
1
Information Reports
1
Information Sharing
1
Initial Public Offerings
1
Inpatient Rehab Facilities
1
Inspection Rights
1
Integra
1
Inter Partes Reexamination
1
intercha
1
InterDigital Communications v ITC
1
Interest Rate Adjustments
1
Interest Rates
1
InterMune
1
International Harmonization
1
Internet of Things
1
Internet Retailers
1
INTERPOL
1
Interpretive Rule
1
Inventions
1
Investment Adviser
1
Investment Advisers Act of 1940
1
Investment Trust Companies
1
IPAB
1
Iran Sanctions
1
IRF Claim Processing
1
Issue Preclusion
1
JAMA
1
Janssen v Celltrion
1
Janus Capital Group
1
Joinder
1
Joint Venture
1
Journalists
1
Judicial Review
1
Jury Awards
1
Jury Trial
1
Justiciable Controversy
1
King v Burwell
1
KPMG
1
LabMD
1
Law Enforcement
1
Leave to Amend
1
Legal History
1
Legal Perspectives
1
Lipitor
1
Litigation Hold
1
Litigation Privilege
1
Litigation Strategies
1
Lobbyists
1
Local Ordinance
1
Loss Causation
1
MA Supreme Judicial Court
1
Managed Care Contracts
1
Manufacturing Facilities
1
Marijuana Cultivation
1
Marijuana Related Businesses
1
Market Manipulation
1
Market Research
1
Marketing Exclusivity Periods
1
MasterCard
1
Material Misrepresentation
1
Material Misstatements
1
MCOs
1
Medicaid Act
1
Medicaid Reimbursements
1
Medical Expenses
1
Medical Foods
1
Medical Liability
1
Medical License
1
Medical Records
1
Medical Supplies
1
Medicare Access and CHIP Reauthorization (MACRA)
1
Medicare Modernization Act
1
Memorandum of Understanding
1
Mental Health Initiatives
1
Merrill Lynch v Manning